Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

During the Trading Day
5.91 -0.03 / -0.51%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.90 -0.01 / -0.17%
 
Volume: 5.8K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues6.1M26.9M6.6M12.3M
 
 
 
 
 
Cost of Goods Sold11.3M12.2M11.2M6.1M
 
 
 
 
 
Depreciation And Amortization876.0K929.0K971.0K926.0K
 
 
 
 
 
 
Operating ExpensesGross Income-6.1M13.8M-5.5M5.3M
 
 
 
 
 
General Expenses19.0M19.9M20.0M27.0M
 
 
 
 
 
Research And Development12.2M11.8M11.8M18.6M
 
 
 
 
 
Total Operating Expenses31.2M33.0M32.1M34.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.1M-6.1M-25.5M-21.6M
 
 
 
 
 
Interest Expense On Debt2.5M2.5M2.6M2.6M
 
 
 
 
 
Other Expenses0.000.0086.4M11.5M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.6M-8.6M58.3M-12.7M
 
 
 
 
 
Net Income-27.6M-8.6M58.3M-12.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS131.8M133.8M139.8M141.4M
 
 
 
 
 
Shares To Calculate EPS Diluted131.8M133.8M166.3M141.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.06$0.37-$0.09
 
 
 
 
 
EPS Diluted-$0.21-$0.06$0.37-$0.09